Moderna on Friday unveiled its strategy to combat the new COVID-19 B.1.1.529 variant known as Omicron, joining rivals Pfizer and Johnson & Johnson, who detailed their own plans on the same day.
The new variant of Omicron was discovered in South Africa, and the World Health Organization has identified it as a highly transmissible ‘variant of concern’ due to concerns that it may be a variant of Omicron. escape that eludes currently available coronavirus vaccines.
FLASHBACK: BIDEN SUGGESTED TRAVEL BAN AGAINST TRUMP CORONAVIRUS WAS ‘XENOPHOBIC’
Also on Friday, the Biden administration decided to restrict travel from eight countries in southern Africa in response to the emergence of Omicron.
Moderna said in a press release that he had previously tested a booster in healthy adults containing double the currently permitted dose. The drugmaker also “clinically studied two multivalent booster candidates designed to anticipate mutations such as those that have appeared in the Omicron variant,” the company said.
OMICRON COVID-19 VARIANT: HERE’S WHAT WE KNOW
As a third pillar of its strategy, Moderna said it would “rapidly advance a specific Omicron booster candidate,” nothing the company “has repeatedly demonstrated to be able to get new candidates through clinical testing. in 60 to 90 days ”.
“From the start, we have said that as we seek to defeat the pandemic, it is imperative that we be proactive as the virus evolves,” Moderna CEO Stéphane Bancel said in a statement. “Mutations in the Omicron variant are cause for concern and for the past several days we have been working to execute our strategy as quickly as possible to combat this variant. “
|JNJ||JOHNSON & JOHNSON||159.20||-1.04||-0,65%|
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Pfizer and BioNTech announced that their joint COVID-19 mRNA vaccine could be changed within 100 days to specifically counter Omicron, while Johnson & Johnson told FOX Business it is already testing its vaccine against the new variant.
Julia Musto of FOX Business and Peter Aitken of FOX News contributed to this report.